Status:
UNKNOWN
7-valent Pneumococcal Conjugated Vaccination
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Conditions:
Invasive Pneumococcal Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Hypothesis: the efficacy of 2 doses 7-valent PCV is equivalent to 1 dose 7-valent PCV.
Detailed Description
Background: Patients with human immunodeficiency virus (HIV) infection have higher incidence and recurrence rates of pneumonia and bacteremia caused by Streptococcus pneumoniae compared with the pers...
Eligibility Criteria
Inclusion
- HIV-infected patients with age \>18 years
Exclusion
- concurrent immunosuppressant use
- Pregnant women
- receipt of other vaccine within 3 months
- active opportunistic infection
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2010
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT00885625
Start Date
March 1 2009
End Date
April 1 2010
Last Update
July 15 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100